The Role of Ikaros in CD8+ T cell Biology

Loading...
Thumbnail Image
Degree type
Doctor of Philosophy (PhD)
Graduate group
Immunology
Discipline
Subject
CD8+ T cells
CTLs
Epigenetics
Ikaros
Transcription Factors
Allergy and Immunology
Immunology and Infectious Disease
Medical Immunology
Funder
Grant number
License
Copyright date
2014-08-22T20:13:00-07:00
Distributor
Related resources
Contributor
Abstract

Naive CD8+ T cells represent one of the most potent cells in immunity, as they can differentiate into cytolytic T lymphocytes (CTLs) that lyses virally infected cells or tumor cells through the production of IFN-g, TNF-a, Perforin and Granzyme B. Their ability to differentiate into highly potent CTLs needs to be a tightly regulated process in order to prevent autoimmunity and disease. However, activation in the absence of key support such as cytokine signals or CD4+ T cell help, or constant challenge with antigen can result in hyporesponsiveness of CD8+ T cells and their failure to mount a robust immune response. Interest has grown in studying the epigenetics of T cells, as chromatin accessibility of key cytokine and lytic mediator loci can determine the ability of the T cell to respond to antigen. Identifying the transcriptional regulators of naive CD8+ T cell differentiation and activation is key to learning how to modulate the CD8+ T cell response. Ikaros is a chromatin-remodeling factor that has been identified to regulate autocrine IL-2 production by and the differentiation program of CD4+ T cells in response to TCR and CD28 signals. As CD8+ T cells make little IL-2 and are dependent on paracrine IL-2 or inflammatory signals for their differentiation, we hypothesized that Ikaros could regulate naïve CD8+ T cell differentiation through restriction of autocrine IL-2 production. In this thesis, I demonstrate that naïve CD8+ T cells with only one copy of Ikaros can differentiate in vitro into cytolytic effectors with enhanced effector function, and this results from increased autocrine IL-2 production. This enhanced effector function also sparked an investigation into pre-clinical models of cellular immunotherapy for cancer, to determine if the Ikzf1+/- CTLs had enhanced anti-tumor function. In conclusion, modulating Ikaros activity represents a new approach to controlling naïve CD8+ T cell differentiation and effector function. Through being able to produce more autocrine IL-2, an Ikzf1+/- CD8+ T cell may not require paracrine IL-2 from CD4+ T cells and can possibly resist the "exhausted" CD8+ T cell effector state during chronic antigen exposure. Thus, investigating Ikaros' role in CD8+ T cell biology will help to elucidate how this chromatin remodeling factor can influence appropriate CD8+ T cells responses to self and foreign antigen, and ensure against inappropriate immunopathology caused by activated CD8+ T cells.

Advisor
Andrew Wells
Date of degree
2013-01-01
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation